Search Results

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Item

Croconaine-Based Polymer Particles as Contrast Agents for Photoacoustic Imaging

2020, Jansen, Felicitas, Lamla, Markus, Mauthe, Diana, Fischer, Stephan, Barth, Holger, Kuehne, Alexander J.C.

In the development and optimization of imaging methods, photoacoustic imaging (PAI) has become a powerful tool for preclinical biomedical diagnosis and detection of cancer. PAI probes can improve contrast and help identify pathogenic tissue. Such contrast agents must meet several requirements: they need to be biocompatible, and absorb strongly in the near-infrared (NIR) range, while relaxing the photoexcited state thermally and not radiatively. In this work, polymer nanoparticles are produced with croconaine as a monomer unit. Small molecular croconaine dyes are known to act as efficient pigments, which do not show photoluminescence. Here, for the first time croconaine copolymer nanoparticles are produced from croconic acid and a range of aromatic diamines. Following a dispersion polymerization protocol, this approach yields monodisperse particles of adjustable size. All synthesized polymers exhibit broad absorption within the NIR spectrum and therefore represent suitable candidates as contrast agents for PAI. The optical properties of these polymer particles are discussed with respect to the relation between particle size and outstanding photoacoustic performance. Biocompatibility of the polymer particles is demonstrated in cell viability experiments. © The Authors. Published by Wiley-VCH GmbH

Loading...
Thumbnail Image
Item

Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications

2017, Chakrabortty, Sabyasachi, Agrawalla, Bikram Keshari, Stumper, Anne, Vegi, Naidu M., Fischer, Stephan, Reichardt, Christian, Kögler, Michael, Dietzek, Benjamin, Feuring-Buske, Michaela, Buske, Christian, Rau, Sven, Weil, Tanja

Organelle-targeted photosensitization represents a promising approach in photodynamic therapy where the design of the active photosensitizer (PS) is very crucial. In this work, we developed a macromolecular PS with multiple copies of mitochondria-targeting groups and ruthenium complexes that displays highest phototoxicity toward several cancerous cell lines. In particular, enhanced anticancer activity was demonstrated in acute myeloid leukemia cell lines, where significant impairment of proliferation and clonogenicity occurs. Finally, attractive two-photon absorbing properties further underlined the great significance of this PS for mitochondria targeted PDT applications in deep tissue cancer therapy.